Literature DB >> 1898295

Medical considerations for human exposure to acceleration-induced loss of consciousness.

J E Whinnery1.   

Abstract

Unconsciousness in humans has probably been occurring since before recorded history. Acceleration-induced loss of consciousness (G-LOC) in flight has been occurring since 1919. Loss of consciousness and syncope are common occurrences in clinical medicine with G-LOC, occurring in a large number of aircrew and research subjects during centrifuge exposures. Although the major risk to humans exposed to centrifuge-induced G-LOC is related directly to the central nervous, cardiac, and musculoskeletal (neck and back) systems, other risks are also present. Human exposure to G-LOC is required to help solve the G-LOC problem in aviators. To perform such human research, the benefits must clearly outweigh the risks to the human. Even if the risk-benefit ratio is considered favorably balanced, continued monitoring of individuals exposed to G-LOC is mandatory. To facilitate monitoring of humans exposed to G-LOC, a central nervous system (CNS) insult classification system would be of significant value. A suggested classification scheme which considers the type of CNS insult, the history of exposure to G-LOC, and the temporal evolution of potential CNS insult is developed. To date there is no indication that G-LOC episodes have any associated long term or persistent psychophysiological sequelae. Improved acute and long term evaluation of humans exposed to G-LOC are, however, important aspects of conducting G-LOC research with humans. Such research and careful monitoring are necessary to understand and eventually solve the G-LOC problem in aviators.

Entities:  

Mesh:

Year:  1991        PMID: 1898295

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  1 in total

Review 1.  Effects and biological limitations of +Gz acceleration on the autonomic functions-related circulation in rats.

Authors:  Yasuhiro Nishida; Satoshi Maruyama; Ichiro Shouji; Takehito Kemuriyama; Akimasa Tashiro; Hiroyuki Ohta; Kohsue Hagisawa; Megumi Hiruma; Hidetake Yokoe
Journal:  J Physiol Sci       Date:  2016-06-04       Impact factor: 2.781

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.